The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

NACompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2025

Conditions
Flat Epithelia AtypiaIntraductal Papilloma Without Atypia
Interventions
OTHER

Pathologic evaluation of excised tissue

Up to 3 months after excisional biopsy

Trial Locations (18)

10065

Memorial Sloan Kettering Cancer Center, New York

10461

Montefiore Medical Center, The Bronx

15213

University of Pittsburgh, Pittsburgh

20007

Georgetown University, Washington D.C.

20010

MedStar Washington Hospital Center, Washington D.C.

20016

Sibley Memorial Hospital, Washington D.C.

21044

Howard County General Hospital, Columbia

21218

MedStar Union Memorial Hospital, Baltimore

21237

MedStar Franklin Square Medical Center, Baltimore

21287

Johns Hopkins University, Baltimore

27278

University of North Carolina - Hillsborough Campus, Hillsborough

27599

University of North Carolina, Chapel Hill

27710

Duke University, Durham

35294

University of Alabama at Birmingham, Birmingham

46202

Indiana University, Indianapolis

02115

Dana Farber Cancer Institute, Boston

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial SLoan Kettering Bergen, Montvale

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02489617 - The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy | Biotech Hunter | Biotech Hunter